November 13/Folsom, Cal./PRNewswire -- A meta-analysis published in the recent issue of the American Journal of Clinical Nutrition evaluates how the plant-based omega-3 fatty acid alpha-linolenic acid (ALA) offers protective effects on cardiovascular diseases (CVD). The study found ALA to be associated with a lower risk of CVD, particularly coronary heart disease (CHD) death. These findings support the potential heart health benefits of ALA and suggest consumers should obtain adequate amounts of ALA in their diets. Walnuts are a key source of ALA and the only nut that provides a meaningful amount of the essential plant-based omega-3 fatty acid offering 2.5 grams of ALA in a mere handful.
This systematic review incorporated 27 original studies and included 251,049 individuals and found that overall ALA exposure was associated with lower risk of CVD. In fact, in the pooled dietary analysis, each 1g per day increment of ALA intake was associated with a 10% lower risk of CHD death. Previously, the majority of research funding of omega-3 fatty acids have been directed towards marine sources, however recently increased attention has been given to its plant-based counterpart ALA, and has been suggesting that ALA consumption also offers cardiovascular benefits. The researchers believe that there may be a direct or indirect antiarrythmic effect of ALA that could partially explain why ALA appeared protective against CHD. Previous studies have found ALA consumption may lower cholesterol levels, positively affect thrombosis, improve endothelial function and decrease inflammation.